Flomics Biotech

Flomics is a biotechnology company that develops novel blood-based diagnostic tools for a broad range of complex diseases, specializing in cancer detection. Their proprietary technology accurately identifies patterns of cell-free RNA (cfRNA) in blood samples, enabling early diagnosis and personalized treatment strategies. Flomics combines Next-Generation Sequencing (NGS) with advanced bioinformatics and machine learning to provide innovative solutions for liquid biopsies.